Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
martedì, ottobre 27
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Disc Medicine Inc
IRON
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$77.66
3.15
4.23%
Ult. Agg.: Oct 26, 4:22 PM
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Disc Medicine Financials
Disc Medicine (IRON) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Stock Market Today: Dow Jones, S&P 500 Futures Rise as Scott Bessent Links September Inflation to 'Energy Shock' — RCAT, ESLT, STLD in Focus
U.S. stock futures were higher on Monday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Friday's lower close.
Rishabh Mishra
PRO
Disc Medicine Q2 EPS $(1.54) Beats $(1.77) Estimate
Disc Medicine (NASDAQ:IRON) reported quarterly losses of $(1.54) per share which beat the analyst consensus estimate of $(1.77) by 12.99 percent. This is a 2.53 percent increase over losses of $(1.58) per share from the
Benzinga Newsdesk
PRO
Disc Medicine Q1 EPS $(1.65) Beats $(1.73) Estimate
Disc Medicine (NASDAQ:IRON) reported quarterly losses of $(1.65) per share which beat the analyst consensus estimate of $(1.73) by 4.62 percent. This is a 61.76 percent decrease over losses of $(1.02) per share from the
Benzinga Newsdesk
PRO
Disc Medicine Q4 EPS $(1.62) Beats $(1.68) Estimate
Disc Medicine (NASDAQ:IRON) reported quarterly losses of $(1.62) per share which beat the analyst consensus estimate of $(1.68) by 3.34 percent. This is a 65.31 percent decrease over losses of $(0.98) per share from the
Benzinga Newsdesk
PRO
Disc Medicine Q3 EPS $(1.77) Misses $(1.51) Estimate
Disc Medicine (NASDAQ:IRON) reported quarterly losses of $(1.77) per share which missed the analyst consensus estimate of $(1.51) by 16.91 percent. This is a 98.88 percent decrease over losses of $(0.89) per share from
Benzinga Newsdesk
Gold Falls 1%; SLB Posts Better-Than-Expected Q3 Earnings
Avi Kapoor
